SVS.MI

Svas Biosana S.p.A.
MilanEUREQUITY Healthcare DELAYED
Last price
8.26
■ 0.00 (0.00%)
MARKET ·

Price

1D H L Range Vol
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
Prev close
8.26
Day high
8.28
Day low
7.98
Volume
752
Market cap
$43.05M
P/E (TTM)
6.40
52W range
7.68 – 10.80

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
-1.43% -0.1%
1M
-4.62% -8.3%
3M
-9.03% -12.1%
6M
-6.98% -18.0%
YTD
+3.25% -9.0%
1Y
+2.74% -17.3%
3Y
+1.23% -72.9%
5Y

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Unusual options activity

Account required
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
Free account required

Contracts trading at or above their open interest, ranked by notional and where the print landed.

Free account

5 more panels on SVS.MI open with an account.

Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.

Insider net activity

6m · Form 4 rollup
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
Net transactions
0
Buys less sells
Sell : buy shares
Not enough filings
Insider-held shares
3.67M
Total on file

Fundamentals

TTM · reported
Market cap$43.05M
Enterprise value$82.21M
Revenue (TTM)$141.56M
Gross profit$40.08M
EBITDA$17.58M
Net income$6.77M
EPS (TTM)$1.29
Free cash flow$-8.86M
Total cash$37.47M
Total debt$76.41M
Book value / share$12.87
Shares outstanding5.21M
Float1.69M
Short % of float
Dividend yield2.42%
Beta (5Y)0.95

Valuation & profitability ratios

Account required
Trailing P/E6.40
Forward P/E5.99
PEG ratio
Price / sales
Price / book0.64
EV / revenue0.58
EV / EBITDA4.68
Gross margin28.32%
Operating margin8.62%
Profit margin4.78%
Return on equity10.38%
Return on assets4.36%
Debt / equity113.15
Current ratio1.82
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Financial statements

As reported · 5 years · 3 quarters
Blank means not reported, not zero
Line item20252024202320222021YoY
Total revenue $141.54M$122.29M$121.63M$99.51M +15.7%
Operating revenue $141.54M$122.29M$121.63M$99.51M +15.7%
Cost of revenue $85.46M$73.62M$73.99M$58.01M +16.1%
Gross profit $56.08M$48.67M$47.64M$41.50M +15.2%
Total operating expense $43.05M$38.12M$37.91M$33.75M +12.9%
Operating income $13.04M$10.54M$9.73M$7.75M +23.7%
Net interest income -$3.70M-$3.72M-$3.19M-$1.53M +0.4%
Pre-tax income $9.14M$8.01M$6.80M$4.66M +14.1%
Tax provision $2.37M$2.13M$1.67M$1.09M +11.1%
Net income $6.77M$5.87M$5.12M$3.57M +15.2%
Net income to common $6.77M$5.87M$5.12M$3.57M +15.2%
Basic EPS 0.960.660.56
Diluted EPS 0.960.660.56
EBIT $13.27M$12.37M$10.59M$6.52M +7.2%
EBITDA $19.06M$17.62M$15.61M$11.31M +8.2%
Basic shares 5.37M5.41M5.60M
Diluted shares 5.37M5.41M5.60M

Options analytics

Account required
Put / call volume
Put / call open interest
Positioning, not flow
Max pain
ATM implied vol
Nearest strike to spot
Skew (10% OTM)
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
Heaviest put OI

Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.

Free account required

Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.

Earnings

History & consensus estimates
Forward consensus
PeriodEPSAnalystsRevenueGrowth
Current quarter $0
Next quarter $0
Current year 1.27 1 $145.00M +4.2%
Next year 1.38 1 $149.40M +3.0%

Analyst targets & ownership

Account required
Mean target$12.00
High target$12.00
Low target$12.00
Implied upside45.28%
Analyst count1
ConsensusNONE
Strong buy / Buy0 / 1
Hold0
Sell / Strong sell0 / 0
Held by insiders70.35%
Held by institutions4.92%
Institutions holding6
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
8.32
-0.67% from price
SMA 20
8.44
-2.14% from price
SMA 50
8.79
-6.04% from price
SMA 100
8.91
-7.34% from price
SMA 200
8.72
-5.22% from price
EMA 12
8.35
-1.12% from price
EMA 26
8.51
-2.90% from price
EMA 50
8.68
-4.79% from price
RSI (14)
38.4
Neutral
MACD (12,26,9)
-0.15
Hist 0.00
ATR (14)
0.15
1.82% of price
Realised vol 30D
32.3%
Annualised
Bollinger upper
8.78
20, 2σ
Bollinger lower
8.10
20, 2σ
50 / 200 cross
Golden
8.79 vs 8.72
Trend bias
Below 200
-5.22%

Options chain

Account required
ExpirySpot 8.26
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Risk profile

Daily returns · 1Y window
Beta vs SPY
-0.09
Less volatile than market
Correlation to SPY
-0.04
Largely independent
Realised vol 30D
32.3%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-23.7%
Peak to trough
Max drawdown 5Y
-56.0%
Peak to trough
ATR 14
0.15
1.82% of price
Beta (reported)
0.95
5Y monthly, from filing

Dividends & splits

Declared · from the issuer
Forward rate$0.20 / yr
Forward yield2.42%
5-year avg yield
Payout ratio19.33%
Ex-dividend dateJun 1, 2026
Next pay date
Last split
Split date

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.